ALPINE 2: Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric

Project: Research project

Project Details

StatusActive
Effective start/end date10/16/178/31/50

Funding

  • Gilead Sciences, Inc.